U1-nRNP Antibodies PFH848
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
UGT1A1 Gene (GILBERT?S SYNDROME) PFH849
Includes:
Sample: Peripheral Blood in EDTA (3 ml)
Methodology: PCR + SEQUENCING
Reporting: 6 Days (11:00)
Urea PFH850
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Urea (Spot) PFH851
Includes:
Sample: Urine (5 ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Uric Acid PFH852
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Uric Acid PFH853
Includes:
Sample: Urine (25 ml) & 24 hrs Urine Volume
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Urine for Chyle PFH854
Includes:
Sample: Urine (25 ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Urine for Fat Globulins PFH855
Includes:
Sample: Urine (5 ml)
Methodology: Staining & Microscopy
Reporting: 11:00/19:00
Urine for Hemoglobunuria PFH856
Includes:
Sample: Urine (5 ml)
Methodology: Microscopy
Reporting: 11:00/19:00
Urine for Hemosiderin PFH857
Includes:
Sample: Urine (5 ml)
Methodology: Perls Prussian Blue
Reporting: 11:00/19:00
Uterus Cervix with Both Tubes Only PFH858
Includes:
Sample: Paraffin Blocks/ Tissue in neutral formalin
Methodology: IHC
Reporting: 10 days (18:00)
